ACVC Premium Access

Ultra-low-dose twice-daily aspirin improves haemostasis and maintains platelet inhibition in acute coronary syndrome patients receiving ticagrelor

Congress Presentation

About the speaker

Doctor William Parker

University of Sheffield, Sheffield (United Kingdom of Great Britain & Northern Ireland)
0 follower

4 more presentations in this session

Why do we need to combine antiplatelets and anticoagulants?

Speaker: Professor R. De Caterina (Pisa, IT)


Rational to remove aspirin from the cocktail. The story after WOEST...(VIA ZOOM)

Speaker: Professor J. ten Berg (Nieuwegein, NL)


What have we learned in the era of NOACs.

Speaker: Professor F. Verheugt (Amsterdam, NL)


Type of stent, type of antiplatelet, type of anticoagulant. The triad of success.

Speaker: Doctor G. Casella (Bologna, IT)


Access the full session

Anti-thrombotics in patients at simultaneous risk of stroke and stent thrombosis

Speakers: Doctor W. Parker, Professor R. De Caterina, Professor J. ten Berg, Professor F. Verheugt, Doctor G. Casella

About the event


Acute Cardiovascular Care 2018

3 March - 5 March 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb